0
     

Report Added
Report already added
Hospital Injectable Drugs Market - Global Outlook and Forecast 2021-2027

Hospital Injectable Drugs Market - Global Outlook and Forecast 2021-2027

This report contains market size and forecasts of Hospital Injectable Drugs in Global, including the following market information:
Global Hospital Injectable Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Hospital Injectable Drugs market was valued at 39780 million in 2020 and is projected to reach US$ 47610 million by 2027, at a CAGR of 4.6% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hospital Injectable Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital Injectable Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Hospital Injectable Drugs Market Segment Percentages, By Type, 2020 (%)
Generic Sterile Injectables
Sterile Intravenous (IV) Solutions

China Hospital Injectable Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Hospital Injectable Drugs Market Segment Percentages, By Application, 2020 (%)
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases

Global Hospital Injectable Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Hospital Injectable Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Hospital Injectable Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Hospital Injectable Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
Hospira (Pfizer Inc.)
Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane
1 Introduction to Research & Analysis Reports
1.1 Hospital Injectable Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital Injectable Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital Injectable Drugs Overall Market Size
2.1 Global Hospital Injectable Drugs Market Size: 2021 VS 2027
2.2 Global Hospital Injectable Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital Injectable Drugs Players in Global Market
3.2 Top Global Hospital Injectable Drugs Companies Ranked by Revenue
3.3 Global Hospital Injectable Drugs Revenue by Companies
3.4 Top 3 and Top 5 Hospital Injectable Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Hospital Injectable Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital Injectable Drugs Players in Global Market
3.6.1 List of Global Tier 1 Hospital Injectable Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital Injectable Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital Injectable Drugs Market Size Markets, 2021 & 2027
4.1.2 Generic Sterile Injectables
4.1.3 Sterile Intravenous (IV) Solutions
4.2 By Type - Global Hospital Injectable Drugs Revenue & Forecasts
4.2.1 By Type - Global Hospital Injectable Drugs Revenue, 2016-2021
4.2.2 By Type - Global Hospital Injectable Drugs Revenue, 2022-2027
4.2.3 By Type - Global Hospital Injectable Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital Injectable Drugs Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Anesthesia
5.1.4 Anti-Infectives
5.1.5 Parenteral Nutrition
5.1.6 Cardiovascular Diseases
5.2 By Application - Global Hospital Injectable Drugs Revenue & Forecasts
5.2.1 By Application - Global Hospital Injectable Drugs Revenue, 2016-2021
5.2.2 By Application - Global Hospital Injectable Drugs Revenue, 2022-2027
5.2.3 By Application - Global Hospital Injectable Drugs Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Hospital Injectable Drugs Market Size, 2021 & 2027
6.2 By Region - Global Hospital Injectable Drugs Revenue & Forecasts
6.2.1 By Region - Global Hospital Injectable Drugs Revenue, 2016-2021
6.2.2 By Region - Global Hospital Injectable Drugs Revenue, 2022-2027
6.2.3 By Region - Global Hospital Injectable Drugs Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Hospital Injectable Drugs Revenue, 2016-2027
6.3.2 US Hospital Injectable Drugs Market Size, 2016-2027
6.3.3 Canada Hospital Injectable Drugs Market Size, 2016-2027
6.3.4 Mexico Hospital Injectable Drugs Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Hospital Injectable Drugs Revenue, 2016-2027
6.4.2 Germany Hospital Injectable Drugs Market Size, 2016-2027
6.4.3 France Hospital Injectable Drugs Market Size, 2016-2027
6.4.4 U.K. Hospital Injectable Drugs Market Size, 2016-2027
6.4.5 Italy Hospital Injectable Drugs Market Size, 2016-2027
6.4.6 Russia Hospital Injectable Drugs Market Size, 2016-2027
6.4.7 Nordic Countries Hospital Injectable Drugs Market Size, 2016-2027
6.4.8 Benelux Hospital Injectable Drugs Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Hospital Injectable Drugs Revenue, 2016-2027
6.5.2 China Hospital Injectable Drugs Market Size, 2016-2027
6.5.3 Japan Hospital Injectable Drugs Market Size, 2016-2027
6.5.4 South Korea Hospital Injectable Drugs Market Size, 2016-2027
6.5.5 Southeast Asia Hospital Injectable Drugs Market Size, 2016-2027
6.5.6 India Hospital Injectable Drugs Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Hospital Injectable Drugs Revenue, 2016-2027
6.6.2 Brazil Hospital Injectable Drugs Market Size, 2016-2027
6.6.3 Argentina Hospital Injectable Drugs Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital Injectable Drugs Revenue, 2016-2027
6.7.2 Turkey Hospital Injectable Drugs Market Size, 2016-2027
6.7.3 Israel Hospital Injectable Drugs Market Size, 2016-2027
6.7.4 Saudi Arabia Hospital Injectable Drugs Market Size, 2016-2027
6.7.5 UAE Hospital Injectable Drugs Market Size, 2016-2027
7 Players Profiles
7.1 Hospira (Pfizer Inc.)
7.1.1 Hospira (Pfizer Inc.) Corporate Summary
7.1.2 Hospira (Pfizer Inc.) Business Overview
7.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Major Product Offerings
7.1.4 Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue in Global (2016-2021)
7.1.5 Hospira (Pfizer Inc.) Key News
7.2 Baxter
7.2.1 Baxter Corporate Summary
7.2.2 Baxter Business Overview
7.2.3 Baxter Hospital Injectable Drugs Major Product Offerings
7.2.4 Baxter Hospital Injectable Drugs Revenue in Global (2016-2021)
7.2.5 Baxter Key News
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Corporate Summary
7.3.2 Fresenius Kabi Business Overview
7.3.3 Fresenius Kabi Hospital Injectable Drugs Major Product Offerings
7.3.4 Fresenius Kabi Hospital Injectable Drugs Revenue in Global (2016-2021)
7.3.5 Fresenius Kabi Key News
7.4 Sandoz (Novartis)
7.4.1 Sandoz (Novartis) Corporate Summary
7.4.2 Sandoz (Novartis) Business Overview
7.4.3 Sandoz (Novartis) Hospital Injectable Drugs Major Product Offerings
7.4.4 Sandoz (Novartis) Hospital Injectable Drugs Revenue in Global (2016-2021)
7.4.5 Sandoz (Novartis) Key News
7.5 Hikma Pharmaceuticals PLC
7.5.1 Hikma Pharmaceuticals PLC Corporate Summary
7.5.2 Hikma Pharmaceuticals PLC Business Overview
7.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Major Product Offerings
7.5.4 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue in Global (2016-2021)
7.5.5 Hikma Pharmaceuticals PLC Key News
7.6 Dr. Reddy’s Laboratories Ltd
7.6.1 Dr. Reddy’s Laboratories Ltd Corporate Summary
7.6.2 Dr. Reddy’s Laboratories Ltd Business Overview
7.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Major Product Offerings
7.6.4 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue in Global (2016-2021)
7.6.5 Dr. Reddy’s Laboratories Ltd Key News
7.7 Grifols
7.7.1 Grifols Corporate Summary
7.7.2 Grifols Business Overview
7.7.3 Grifols Hospital Injectable Drugs Major Product Offerings
7.4.4 Grifols Hospital Injectable Drugs Revenue in Global (2016-2021)
7.7.5 Grifols Key News
7.8 Nichi-Iko Group (Sagent)
7.8.1 Nichi-Iko Group (Sagent) Corporate Summary
7.8.2 Nichi-Iko Group (Sagent) Business Overview
7.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Major Product Offerings
7.8.4 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue in Global (2016-2021)
7.8.5 Nichi-Iko Group (Sagent) Key News
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Corporate Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Hospital Injectable Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Hospital Injectable Drugs Revenue in Global (2016-2021)
7.9.5 Teva Pharmaceutical Key News
7.10 Otsuka
7.10.1 Otsuka Corporate Summary
7.10.2 Otsuka Business Overview
7.10.3 Otsuka Hospital Injectable Drugs Major Product Offerings
7.10.4 Otsuka Hospital Injectable Drugs Revenue in Global (2016-2021)
7.10.5 Otsuka Key News
7.11 B.Braun
7.11.1 B.Braun Corporate Summary
7.11.2 B.Braun Business Overview
7.11.3 B.Braun Hospital Injectable Drugs Major Product Offerings
7.11.4 B.Braun Hospital Injectable Drugs Revenue in Global (2016-2021)
7.11.5 B.Braun Key News
7.12 JW Life Science
7.12.1 JW Life Science Corporate Summary
7.12.2 JW Life Science Business Overview
7.12.3 JW Life Science Hospital Injectable Drugs Major Product Offerings
7.12.4 JW Life Science Hospital Injectable Drugs Revenue in Global (2016-2021)
7.12.5 JW Life Science Key News
7.13 Auromedics
7.13.1 Auromedics Corporate Summary
7.13.2 Auromedics Business Overview
7.13.3 Auromedics Hospital Injectable Drugs Major Product Offerings
7.13.4 Auromedics Hospital Injectable Drugs Revenue in Global (2016-2021)
7.13.5 Auromedics Key News
7.14 Sanofi
7.14.1 Sanofi Corporate Summary
7.14.2 Sanofi Business Overview
7.14.3 Sanofi Hospital Injectable Drugs Major Product Offerings
7.14.4 Sanofi Hospital Injectable Drugs Revenue in Global (2016-2021)
7.14.5 Sanofi Key News
7.15 Gland Pharma
7.15.1 Gland Pharma Corporate Summary
7.15.2 Gland Pharma Business Overview
7.15.3 Gland Pharma Hospital Injectable Drugs Major Product Offerings
7.15.4 Gland Pharma Hospital Injectable Drugs Revenue in Global (2016-2021)
7.15.5 Gland Pharma Key News
7.16 Endo International PLC
7.16.1 Endo International PLC Corporate Summary
7.16.2 Endo International PLC Business Overview
7.16.3 Endo International PLC Hospital Injectable Drugs Major Product Offerings
7.16.4 Endo International PLC Hospital Injectable Drugs Revenue in Global (2016-2021)
7.16.5 Endo International PLC Key News
7.17 Sichuan Kelun Pharmaceutical
7.17.1 Sichuan Kelun Pharmaceutical Corporate Summary
7.17.2 Sichuan Kelun Pharmaceutical Business Overview
7.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Major Product Offerings
7.17.4 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue in Global (2016-2021)
7.17.5 Sichuan Kelun Pharmaceutical Key News
7.18 Cisen Pharmaceutical
7.18.1 Cisen Pharmaceutical Corporate Summary
7.18.2 Cisen Pharmaceutical Business Overview
7.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Major Product Offerings
7.18.4 Cisen Pharmaceutical Hospital Injectable Drugs Revenue in Global (2016-2021)
7.18.5 Cisen Pharmaceutical Key News
7.19 Shijiazhuang No. 4 Pharmaceutical
7.19.1 Shijiazhuang No. 4 Pharmaceutical Corporate Summary
7.19.2 Shijiazhuang No. 4 Pharmaceutical Business Overview
7.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Major Product Offerings
7.19.4 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue in Global (2016-2021)
7.19.5 Shijiazhuang No. 4 Pharmaceutical Key News
7.20 Shandong Hualu Pharmaceutical
7.20.1 Shandong Hualu Pharmaceutical Corporate Summary
7.20.2 Shandong Hualu Pharmaceutical Business Overview
7.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Major Product Offerings
7.20.4 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue in Global (2016-2021)
7.20.5 Shandong Hualu Pharmaceutical Key News
7.21 CR Double-Crane
7.21.1 CR Double-Crane Corporate Summary
7.21.2 CR Double-Crane Business Overview
7.21.3 CR Double-Crane Hospital Injectable Drugs Major Product Offerings
7.21.4 CR Double-Crane Hospital Injectable Drugs Revenue in Global (2016-2021)
7.21.5 CR Double-Crane Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Hospital Injectable Drugs Market Opportunities & Trends in Global Market
Table 2. Hospital Injectable Drugs Market Drivers in Global Market
Table 3. Hospital Injectable Drugs Market Restraints in Global Market
Table 4. Key Players of Hospital Injectable Drugs in Global Market
Table 5. Top Hospital Injectable Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Hospital Injectable Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Hospital Injectable Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Hospital Injectable Drugs Product Type
Table 9. List of Global Tier 1 Hospital Injectable Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital Injectable Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Hospital Injectable Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Hospital Injectable Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Hospital Injectable Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Hospital Injectable Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Hospital Injectable Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Hospital Injectable Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Hospital Injectable Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Hospital Injectable Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Hospital Injectable Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Hospital Injectable Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Hospital Injectable Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Hospital Injectable Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Hospital Injectable Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Hospital Injectable Drugs Revenue, (US$, Mn), 2022-2027
Table 30. Hospira (Pfizer Inc.) Corporate Summary
Table 31. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Offerings
Table 32. Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 33. Baxter Corporate Summary
Table 34. Baxter Hospital Injectable Drugs Product Offerings
Table 35. Baxter Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 36. Fresenius Kabi Corporate Summary
Table 37. Fresenius Kabi Hospital Injectable Drugs Product Offerings
Table 38. Fresenius Kabi Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 39. Sandoz (Novartis) Corporate Summary
Table 40. Sandoz (Novartis) Hospital Injectable Drugs Product Offerings
Table 41. Sandoz (Novartis) Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Hikma Pharmaceuticals PLC Corporate Summary
Table 43. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Offerings
Table 44. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 45. Dr. Reddy’s Laboratories Ltd Corporate Summary
Table 46. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product Offerings
Table 47. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 48. Grifols Corporate Summary
Table 49. Grifols Hospital Injectable Drugs Product Offerings
Table 50. Grifols Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 51. Nichi-Iko Group (Sagent) Corporate Summary
Table 52. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Offerings
Table 53. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 54. Teva Pharmaceutical Corporate Summary
Table 55. Teva Pharmaceutical Hospital Injectable Drugs Product Offerings
Table 56. Teva Pharmaceutical Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 57. Otsuka Corporate Summary
Table 58. Otsuka Hospital Injectable Drugs Product Offerings
Table 59. Otsuka Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 60. B.Braun Corporate Summary
Table 61. B.Braun Hospital Injectable Drugs Product Offerings
Table 62. B.Braun Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 63. JW Life Science Corporate Summary
Table 64. JW Life Science Hospital Injectable Drugs Product Offerings
Table 65. JW Life Science Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 66. Auromedics Corporate Summary
Table 67. Auromedics Hospital Injectable Drugs Product Offerings
Table 68. Auromedics Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 69. Sanofi Corporate Summary
Table 70. Sanofi Hospital Injectable Drugs Product Offerings
Table 71. Sanofi Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 72. Gland Pharma Corporate Summary
Table 73. Gland Pharma Hospital Injectable Drugs Product Offerings
Table 74. Gland Pharma Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 75. Endo International PLC Corporate Summary
Table 76. Endo International PLC Hospital Injectable Drugs Product Offerings
Table 77. Endo International PLC Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 78. Sichuan Kelun Pharmaceutical Corporate Summary
Table 79. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Offerings
Table 80. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 81. Cisen Pharmaceutical Corporate Summary
Table 82. Cisen Pharmaceutical Hospital Injectable Drugs Product Offerings
Table 83. Cisen Pharmaceutical Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 84. Shijiazhuang No. 4 Pharmaceutical Corporate Summary
Table 85. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Offerings
Table 86. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 87. Shandong Hualu Pharmaceutical Corporate Summary
Table 88. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Offerings
Table 89. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 90. CR Double-Crane Corporate Summary
Table 91. CR Double-Crane Hospital Injectable Drugs Product Offerings
Table 92. CR Double-Crane Hospital Injectable Drugs Revenue (US$, Mn), (2016-2021)

List of Figures
Figure 1. Hospital Injectable Drugs Segment by Type
Figure 2. Hospital Injectable Drugs Segment by Application
Figure 3. Global Hospital Injectable Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hospital Injectable Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Hospital Injectable Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital Injectable Drugs Revenue in 2020
Figure 8. By Type - Global Hospital Injectable Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global Hospital Injectable Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global Hospital Injectable Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America Hospital Injectable Drugs Revenue Market Share, 2016-2027
Figure 12. US Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Hospital Injectable Drugs Revenue Market Share, 2016-2027
Figure 16. Germany Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Hospital Injectable Drugs Revenue Market Share, 2016-2027
Figure 24. China Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Hospital Injectable Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Hospital Injectable Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Hospital Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Baxter Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Fresenius Kabi Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Sandoz (Novartis) Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Grifols Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Teva Pharmaceutical Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Otsuka Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. B.Braun Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. JW Life Science Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Auromedics Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Sanofi Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Gland Pharma Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Endo International PLC Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Cisen Pharmaceutical Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Report Title: Hospital Injectable Drugs Market - Global Outlook and Forecast 2021-2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW